Impact of Novel Medications and Out-Of-Pocket Costs in Managing Cardiovascular Disease

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year.

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Target trial emulation study finds no added effectiveness or persistence with combination therapy for plaque psoriasis.

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

A post-hoc analysis of EPCORE-NHL-1 was presented at ASCO.

Abstracts presented during the plenary session of the 2025 European Hematology Association (EHA) Congress spanned from novel drug regimens for myeloma and lymphoma to investigation of leukemias on the molecular and genetic levels.